Immunax’s active ingredient VDBP-MAF is a complex protein produced by the sequential deglycosylation of Vitamin D Binding Protein (VDBP). VDBP-MAF is a naturally-occurring messenger molecule that directs and coordinates immune cells. Developed by our research team to support and optimize immune function, Immunax activates the body’s natural immune defense systems and improves clinical outcomes for patients with weakened immune function.
Immunax functions like the commanding officer of your immune system. VDBP-MAF is a messenger protein that regulates the immune response. All healthy individuals naturally produce VDBP-MAF. Unfortunately, in people with chronic diseases it is often suppressed or depleted. iMAP therapy provides therapeutic benefits for a range of conditions, including:
As a stabilized vitamin D protein complex containing both precursor (VDBP) and active (VDBP-MAF) ingredients, Immunax exerts its actions through the vitamin D axis and pathways to modulate macrophage activity. It boosts innate immune function by increasing vitamin D half-life and activates macrophages, which coordinate an integrated immune response.
Activated macrophages have diverse positive actions in the human body such as eliminating cancer cells, protecting against infections, and initiating repair and regeneration of the brain and central nervous system.
Over 30+ years of scientific research shows that Immunax may help to promote a wide range of beneficial physiological effects. Different effects will provide therapeutic benefits for different diseases.
These statements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. These results are not typical. Individual results may vary.
At Regenerative Medicine Limited, we pride ourselves on the ability to change and impact lives in a healthy way. Curious to find out more? Get in touch with a member of our team today.